-
Signature
-
/s/ Mark S. Livingston
-
Issuer symbol
-
PGNY
-
Transactions as of
-
04 Mar 2024
-
Net transactions value
-
-$774,823
-
Form type
-
4
-
Filing time
-
03 Apr 2024, 17:16:58 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PGNY |
Common Stock |
Award |
$0 |
+15,000 |
+40% |
$0.000000 |
52,248 |
04 Mar 2024 |
Direct |
F1 |
| transaction |
PGNY |
Common Stock |
Options Exercise |
$81,477 |
+20,627 |
+39% |
$3.95* |
72,875 |
01 Apr 2024 |
Direct |
|
| transaction |
PGNY |
Common Stock |
Tax liability |
$436,320 |
-11,591 |
-16% |
$37.64 |
61,284 |
01 Apr 2024 |
Direct |
F2 |
| transaction |
PGNY |
Common Stock |
Sale |
$80,050 |
-2,129 |
-3.5% |
$37.60 |
59,155 |
01 Apr 2024 |
Direct |
F3 |
| transaction |
PGNY |
Common Stock |
Sale |
$339,929 |
-9,036 |
-15% |
$37.62 |
50,119 |
01 Apr 2024 |
Direct |
F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PGNY |
Stock Option (Right to Buy) |
Award |
$0 |
+45,000 |
|
$0.000000 |
45,000 |
04 Mar 2024 |
Common Stock |
45,000 |
$35.48 |
Direct |
F4 |
| transaction |
PGNY |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-20,627 |
-100% |
$0.000000* |
0 |
01 Apr 2024 |
Common Stock |
20,627 |
$3.95 |
Direct |
F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: